Heerma Peter Insider Trading Activity

Average Profitability
<0.0001%
Insider Buys Quantity
0
Insider Buys Sum
$0
Insider Sells Quantity
22
Insider Sells Sum
$925,573.24

Insider Activity of Heerma Peter

According to the SEC Form 4 filings, Heerma Peter, being in a position of

  1. EVP, CHIEF COMMERCIAL OFFICER at Travere Therapeutics, Inc.,
    оver the last 12 months, has bought 0 shares, and sold 304868 shares for $18.7M,
    over all time since 2020-10-02, has bought 0 shares, and sold 359908 shares for $19.9M.

Biography of Heerma Peter

No biography is available at this moment.

Statistics of Insider Transactions Last Year

Amount of Insider Buys and Sells by Stocks

Buys
 $000
Sells
 $18,695,7617100

Comparison of Insiders on Amount of Buys and Sells

2026-09-17SaleTravere Therapeutics, Inc.
TVTX
EVP, CHIEF COMMERCIAL OFFICER
8,282
0.009%
$65.07$538,917-18.78%
2026-09-16SaleTravere Therapeutics, Inc.
TVTX
EVP, CHIEF COMMERCIAL OFFICER
172,717
0.1856%
$63.43$10.96M-17.01%
2026-09-15SaleTravere Therapeutics, Inc.
TVTX
EVP, CHIEF COMMERCIAL OFFICER
102,190
0.1095%
$62.26$6.36M-15.55%
2026-05-05SaleTravere Therapeutics, Inc.
TVTX
CHIEF COMMERCIAL OFFICER
2,174
0.0024%
$46.65$101,417+25.7%
2026-04-14SaleTravere Therapeutics, Inc.
TVTX
CHIEF COMMERCIAL OFFICER
7,215
0.0104%
$41.93$302,516+31.88%
2026-02-03SaleTravere Therapeutics, Inc.
TVTX
CHIEF COMMERCIAL OFFICER
7,310
0.008%
$32.12$234,797+53.44%
2025-12-24SaleTravere Therapeutics, Inc.
TVTX
CHIEF COMMERCIAL OFFICER
4,980
0.0055%
$40.00$199,200+14.65%
2025-10-31SaleTravere Therapeutics, Inc.
TVTX
CHIEF COMMERCIAL OFFICER
5,591
0.0064%
$35.00$195,685+21.15%
2025-10-28SaleTravere Therapeutics, Inc.
TVTX
CHIEF COMMERCIAL OFFICER
2,662
0.0032%
$30.00$79,860+41.33%
2025-05-05SaleTravere Therapeutics, Inc.
TVTX
CHIEF COMMERCIAL OFFICER
1,771
0.002%
$21.05$37,280+29.47%
2025-02-12SaleTravere Therapeutics, Inc.
TVTX
CHIEF COMMERCIAL OFFICER
2,568
0.0029%
$23.53$60,426-9.09%
2025-02-11SaleTravere Therapeutics, Inc.
TVTX
CHIEF COMMERCIAL OFFICER
3,074
0.0042%
$25.00$76,850-11.2%
2025-02-03SaleTravere Therapeutics, Inc.
TVTX
CHIEF COMMERCIAL OFFICER
5,166
0.0058%
$20.12$103,940+4.3%
2025-01-22SaleTravere Therapeutics, Inc.
TVTX
CHIEF COMMERCIAL OFFICER
1,584
0.0018%
$18.94$30,002+6.94%
2024-09-09SaleTravere Therapeutics, Inc.
TVTX
CHIEF COMMERCIAL OFFICER
2,191
0.0026%
$11.52$25,240+37.44%
2024-02-01SaleTravere Therapeutics, Inc.
TVTX
CHIEF COMMERCIAL OFFICER
4,195
0.0053%
$8.53$35,789+5.29%
2024-01-23SaleTravere Therapeutics, Inc.
TVTX
CHIEF COMMERCIAL OFFICER
1,559
0.002%
$9.07$14,138-3.12%
2023-10-03SaleTravere Therapeutics, Inc.
TVTX
Chief Commercial Officer
3,091
0.004%
$8.25$25,504-6.37%
2023-02-01SaleTravere Therapeutics, Inc.
TVTX
Chief Commercial Officer
1,779
0.0026%
$21.75$38,697-30.47%
2023-01-24SaleTravere Therapeutics, Inc.
TVTX
Chief Commercial Officer
1,550
0.0023%
$21.90$33,952-28.72%
Total: 31
Company
About Prismo.proIdeasArticlesPrivacy PolicyTerms of ServiceContact Us
Screener Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksStock NewsInsider RatioList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.